Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-13-002122
Filing Date
2013-04-22
Accepted
2013-04-22 12:18:46
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT AMENDMENT hbmk_10ka.htm 10-K/A 76006
  Complete submission text file 0001354488-13-002122.txt   3475395

Data Files

Seq Description Document Type Size
2 hbmk-20121231.xml EX-101.INS 545786
3 hbmk-20121231.xsd EX-101.SCH 46254
4 hbmk-20121231_cal.xml EX-101.CAL 58055
5 hbmk-20121231_def.xml EX-101.DEF 77915
6 hbmk-20121231_lab.xml EX-101.LAB 259602
7 hbmk-20121231_pre.xml EX-101.PRE 187085
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-53231 | Film No.: 13773223
SIC: 2834 Pharmaceutical Preparations